domain | ucl.ac.uk |
summary | The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed Lecanemab for use in the early stages of Alzheimer's disease in the UK, following decades of research supported by UCL. This is a significant moment as it is the first drug approved for early Alzheimer's disease. Additionally, UCL research excellence and its positive real-world impact have improved since 2014 according to the Research Excellence Framework (REF) 2021 assessment results announced today. |
title | UCL - London's Global University |
description | UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021). |
keywords | research, students, school, graduate, event, search, programmes, summer, browse, london, study, courses, events, view, university, short, world |
upstreams |
futurelearn.com |
downstreams |
|
nslookup | A 144.82.250.24 |
created | 2024-10-12 |
updated | 2024-10-21 |
|
|